List of Loreev Xr drug patents

Loreev Xr is owned by Almatica.

Loreev Xr contains Lorazepam.

Loreev Xr has a total of 1 drug patent out of which 0 drug patents have expired.

Loreev Xr was authorised for market use on 27 August, 2021.

Loreev Xr is available in capsule, extended release;oral dosage forms.

Loreev Xr can be used as once daily treatment of anxiety disorder in adults.

The generics of Loreev Xr are possible to be released after 08 January, 2034.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8999393 ALMATICA Sustained release formulations of lorazepam
Jan, 2034

(10 years from now)

Do you want to check out LOREEV XR patents from before 2022?

Drugs and Companies using LORAZEPAM ingredient

Market Authorisation Date: 27 August, 2021

Treatment: Once daily treatment of anxiety disorder in adults


More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic